All In MedTech

FDA Clearance Tracker · P050012-S016

DEXCOM SEVEN SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 13, 2009 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 13, 2009

Approved

Time to decision

193 days

Received Aug 4, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P050012-S016
Device name
DEXCOM SEVEN SYSTEM
Applicant
Dexcom, Inc.
Applicant location
San Diego, CA
Received
Aug 4, 2008
Decided
Feb 13, 2009
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P050012

Device type

Device class
Class III

Every decision under product code MDS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODIFICATIONS TO THE RECEIVER USER INTERFACE AND ALGORITHM, AND MODIFICATIONS TO THE TRANSMITTER TO MAKE IT COMPATIBLE TO THE MODIFIED RECEIVER ALGORITHM.

Source documents

Other decisions for Dexcom, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.